MD, PhD, MAE, FMedSci, FRSB, FRCP, FRCPEd.

Brillia for Children is probably the most amazing homeopathic quackery I have ever encountered:

Uses: Enhance clarity, improve concentration of attention, reduce feelings of anxiety & stress, excitability, irritability and hyperactivity to improve attention, focus and mood regulation.

Active Ingredient: Lapine S-100 immune globulin mixture of homeopathic dilutions 12C, 30C and 50C.

Brillia is a unique combination of antibody science and homeopathic formulation. The active ingredient of Brillia is antibodies to the brain-specific S100 protein (S100B). This protein is an important regulator of many different intracellular and extracellular brain processes, e.g. various enzymes activities, calcium homeostasis, communication between neurons, etc. Since almost all mental and neurological diseases as well as temporal stress-induced conditions are accompanied by disturbance of the above-mentioned processes, especially communication between neurons, the normalization of these processes is considered to be a prospective way to treat people with such undesirable conditions. Brillia is an antibody conjugated to the S100B protein and does not alter the concentration of the S100B protein in the bloodstream. Brillia’s efficacy stems from its ability to regulate the activity of the S100B protein and does not alter its concentration. In order for a protein to have an effect in the body, it needs to bind to its target, such as an enzyme. Proteins have very specific conformations that ensure that only the correct protein binds to the correct target molecule. Once the protein correctly orients itself into the active site of the target molecule, this is when the protein causes an effect in the body. When Brillia binds to the S100B protein, the overall shape of the protein is altered, hindering its ability to bind to its target molecule and thereby controlling its activity in the body. In short, Brillia stops the S100B protein from acting in the body by changing its shape, consequently regulating levels of anxiety and hyperactivity.

PARENT TOOL | WATCH: DISCOVER BRILLIA

WATCH: WHY & HOW BRILLIA WORKS

Inactive Ingredients: Lactose monohydrate, magnesium stearate, microcrystalline cellulose. Does not contain artificial colors or artificial flavors.

Food Allergy Warning: This product contains lactose. Brillia is gluten free and nut free.

About active ingredients, the website tells us this:

Let’s start off with the active ingredient, registered with the FDA as Lapine S-100B immune globulin. Now we know this name can be intimidating, so we are going to break it down for you. Working backwards, “immune globulin” is just the “sciency” way of saying “antibody”, and don’t worry, we will get into what an antibody actually is in just a second. Next, “S-100B” is the name of the protein the antibody is designed to recognize in the body. Lastly, “Lapine” is just a descriptor of the origin of the antibody, just like the millions of other antibodies used each and every day in laboratories all across the world.

So, what exactly is an antibody? Antibodies are a naturally occurring protein and component of our immune system that are individually programmed to target a very specific protein, in the case of Brillia, the S-100B protein. It is important to understand that antibodies are one of the most specific and targeted molecules in our bodies, resulting in zero off-target effects — meaning that antibodies specifically look for and attach to their target only. This is why Brillia has no harmful side effects, because it only interacts with the S-100B protein. Not only does Brillia have absolutely zero side effects, it also has no contraindications with any other medications or supplements your child may be taking. This is due to Brillia’s extremely high level of target specificity, meaning that Brillia is so well targeted to the S-100B protein, it won’t even think about touching anything else in the body, including any other drugs or supplements.

Now that we know more about the active ingredient, let’s talk about its target, the S-100B protein.

The S-100B protein is a naturally occurring protein and is most prevalent in the brain. It is an important regulator of many processes such as regulating calcium levels and helping neurons communicate, but in our case, we care about how it influences the symptoms we mentioned earlier, such as anxiety and hyperactivity.

Given that S-100B protein influences these symptoms, it is quite intuitive that when the S-100B protein doesn’t do its job properly, these symptoms become more prevalent, and this is exactly what happens in those who suffer from anxiety, hyperactivity, stress and lack of focus.

So, what makes the S-100B protein, for a lack of a better term, mess up? The answer is quite simple, when the S-100B protein is overproduced or overactive, its activity becomes unnecessarily high, making it capable of causing these symptoms.

The firm even has something vaguely resembling evidence: a study that “shows that over the course of 12 weeks, Brillia had a significantly better effect on the severity of anxiety over those that did not take Brillia, therefore proving Brillia’s efficacy.” They show some actual results but the methods or source of the study are not disclosed. On Medline, I could not find it either. Therefore, I asked the firm to send it to me. This is the answer I got:

“Our studies were conducted in Europe and then published on our website. Please click here to view the full details found on our site.”

So, they have a study that they commissioned in Europe; it was done by researchers unnamed. The firm then put some data of it on their website. In other words:

  • we don’t know who was responsible for the study;
  • we cannot evaluate how rigorous it was;
  • it has never been peer-reviewed;
  • it is now being used for promotional purposes.

Personally, I don’t find this acceptable. In my view, this does not provide a legitimation to make far-reaching claims about the remedy. Until I have evidence to the contrary, I thus deem it safe to conclude that Brillia has no effect other than enriching the manufacturer.

7 Responses to Brillia: homeopathic quackery for autistic children?

  • The Lapine 100-S is called an “Active ingredient”. But at 12C and above there isn’t actually any Lapine 100-S in the pills. Is there?

    • Q: How can you tell when a homeopath lies?
      A: When they call something 12C+ an ‘active ingredient’.

      I once tried to get a consumer authority interested in this very claim, because a product’s label should list what’s in there. Listing ingredients that are not actually present is an economic offence, and the product should be taken off the market until the false listing is (haha) remedied.

      But you guessed it: the CA made an exception for homeopathic products, as those were approved for sale by default as a a result of a law from 1932 or so …

      • Q: how can you tell when a homeopath lies?

        A: when they speak.

        Let’s keep it simple.

      • Time for a new law.

        Professor Ernst has raised this anomaly in relation to homeopathic Mercuris Solubilis. If it’s really Mercury, how come they’re selling a poisonous substance without restriction. And if the defence is that there’s no Mercury actually present, how come they’re allowed to sell it as Mercury.

        Lots of other laws of 1930s vintage have been changed or updated – why can’t this one be?

  • It comes from the EU and the company Hadaf limited liability company sounds middle eastern.. something is fishy.

  • An open-access article is published here: https://www.researchgate.net/publication/347737487_Clinical_and_safety_evaluation_of_Brillia_patients_with_Attention-DeficitHyperactivity_Disorder. However, the article does not have a funding statement, which is standard in research journals, and the turnaround time from submission to publication is very short–fifteen days. The journal it is published in has been marked as a deceptive journal.

    Open-access article:
    Allen, Timothy & Dhoalokia, Rashash & Johnson-Park, Sylvia & M.N.V, Giridhar. (2019). Clinical and safety evaluation of Brillia patients with Attention-Deficit/Hyperactivity Disorder. Clinical and Medical Reports. 2. 10.15761/CMR.1000155.

    Deceptive journal:
    Bramstedt, PhD, Katrina. (2020). Unmasking the Hunter: An Exploration of Predatory Publishing. The Journal of Scientific Practice and Integrity. 2. 10.35122/001c.13267.

  • After seeing the commercial thought I’d check it out. It seems for a holistic product, the ingredients seem very questionable buyer beware!

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Subscribe via email

Enter your email address to receive notifications of new blog posts by email.

Recent Comments

Note that comments can be edited for up to five minutes after they are first submitted but you must tick the box: “Save my name, email, and website in this browser for the next time I comment.”

The most recent comments from all posts can be seen here.

Archives
Categories